title: Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling.
authors.affiliation: Department of Surgery, Division of Cardiothoracic Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
authors.forename: Mark F
authors.initials: MF
authors.lastname: Berry
authors.forename: Y Joseph
authors.initials: YJ
authors.lastname: Woo
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Pirolli
authors.forename: Lawrence T
authors.initials: LT
authors.lastname: Bish
authors.forename: Mireille A
authors.initials: MA
authors.lastname: Moise
authors.forename: Jeffrey W
authors.initials: JW
authors.lastname: Burdick
authors.forename: Kevin J
authors.initials: KJ
authors.lastname: Morine
authors.forename: Vasant
authors.initials: V
authors.lastname: Jayasankar
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Gardner
authors.forename: H Lee
authors.initials: HL
authors.lastname: Sweeney
mesh_terms: D000818:Animals; D000068800:Etanercept; D006321:Heart / Q000502:physiology; D006333:Heart Failure / Q000378:metabolism; D006439:Hemodynamics; D007074:Immunoglobulin G / Q000494:pharmacology*; D008297:Male; D020781:Matrix Metalloproteinase 1 / Q000378:metabolism; D009203:Myocardial Infarction / Q000188:drug therapy*; D051381:Rats; D011917:Rats, Inbred Lew; D018124:Receptors, Tumor Necrosis Factor; D011993:Recombinant Fusion Proteins / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D020257:Ventricular Remodeling / Q000187:drug effects*
chemical_list: D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D011993:Recombinant Fusion Proteins; D014409:Tumor Necrosis Factor-alpha; D020781:Matrix Metalloproteinase 1; D000068800:Etanercept